Evidence map›Paper›PMID 24223994›Full record

ArticlePloS one2013

Decreased hematocrit-to-viscosity ratio and increased lactate dehydrogenase level in patients with sickle cell anemia and recurrent leg ulcers.

Philippe Connes, Yann Lamarre, Marie-Dominique Hardy-Dessources, Nathalie Lemonne, Xavier Waltz, Danièle Mougenel, Martin Mukisi-Mukaza, Marie-Laure Lalanne-Mistrih, Vanessa Tarer, Benoit Tressières and 2 more

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03114137 unknown statusnot on this map

Heart, Arteries and Sikle Cell Disease, a Multicentric Cohort of Cardiovascular Complications in Subsaharan Africa

Typeobservational_patient_registrySponsorCardiologie et DéveloppementRan2012 to 2022Enrolled4,500ConditionsSickle Cell Anemia, Sickle Cell Disease
NCT03352986 unknown statusnot on this mapstarted 2017, after this paper: background citation

A Substudy of the CADRE Study: Determination of Clinical Markers in Patients With Extreme Sickle Cell Disease Phenotype

TypeobservationalSponsorCardiologie et DéveloppementRan2017 to 2019Enrolled300ConditionsSickle Cell DiseaseArmsbiological analysis, peripheral arterial tonometry
3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Blood rheology biomarkers in sickle cell disease.Experimental biology and medicine (Maywood, N.J.) · 2020
    Review
  16. Whole-exome sequencing indicatesExperimental biology and medicine (Maywood, N.J.) · 2019
    Article
  17. Review
  18. Erythrocyte Aggregation and Blood Viscosity is Similar in Homozygous Sickle Cell Disease Patients with and without Leg Ulcers.The International journal of angiology : official publication of the International College of Angiology, Inc · 2018
    Article
  19. RX of sickle cell leg ulcers.International wound journal · 2016
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Philippe ConnesUMR Inserm 665, Université des Antilles et de la Guyane, Pointe-à-Pitre, Guadeloupe ; Laboratory of Excellence GR-Ex « The red cell : from genesis to death », PRES Sorbonne Paris Cité, Paris, France ; Laboratoire ACTES (EA 3596)/Département de Physiologie, Université des Antilles et de la Guyane, Pointe-à-Pitre, Guadeloupe.
Yann Lamarre
Marie-Dominique Hardy-Dessources
Nathalie Lemonne
Xavier Waltz
Danièle Mougenel
Martin Mukisi-Mukaza
Marie-Laure Lalanne-Mistrih
Vanessa Tarer
Benoit Tressières
Maryse Etienne-Julan
Marc Romana
Centre Hospitalier Universitaire Pointe-à-Pitre · GPSorbonne Paris Cité · FRLaboratory of Excellence GR-Ex · FRUniversité des Antilles · GP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leg ulcer is a disabling complication in patients with sickle cell anemia (SCA) but the exact pathophysiological mechanisms are unknown. The aim of this study was to identify the hematological and hemorheological alterations associated with recurrent leg ulcers. Sixty-two SCA patients who never experienced leg ulcers (ULC-) and 13 SCA patients with a positive history of recurrent leg ulcers (ULC+)--with no leg ulcers at the time of the study--were recruited. All patients were in steady state condition. Blood was sampled to perform hematological, biochemical (hemolytic markers) and hemorheological analyses (blood viscosity, red blood cell deformability and aggregation properties). The hematocrit-to-viscosity ratio (HVR), which reflects the red blood cell oxygen transport efficiency, was calculated for each subject. Patients from the ULC+ group were older than patients from the ULC- group. Anemia (red blood cell count, hematocrit and hemoglobin levels) was more pronounced in the ULC+ group. Lactate dehydrogenase level was higher in the ULC+ group than in the ULC- group. Neither blood viscosity, nor RBC aggregation properties differed between the two groups. HVR was lower and RBC deformability tended to be reduced in the ULC+ group. Our study confirmed increased hemolytic rate and anemia in SCA patients with leg ulcers recurrence. Furthermore, our data suggest that although systemic blood viscosity is not a major factor involved in the pathophysiology of this complication, decreased red blood cell oxygen transport efficiency (i.e., low hematocrit/viscosity ratio) may play a role.

Indexed as

Blood ViscosityAdultAnemia, Sickle CellFemaleHematocritHumansLactate DehydrogenasesLeg UlcerMaleRecurrenceLactate Dehydrogenases

Identifiers

PMID24223994
PMCPMC3817120
OpenAlexW2136100661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.